Skip to main content
Top
Published in: International Urology and Nephrology 8/2015

01-08-2015 | Urology - Original Paper

Correlation between the androgen receptor status of the appendix testis and the efficacy of human chorionic gonadotropin treatment in undescended testis

Authors: Gyula Drabik, Tamás Józsa, Olga Ruzsnavszky, Kornél Kistamás, Beatrix Dienes, Ilona Kovacs, Mátyás Benyó, Tibor Flaskó

Published in: International Urology and Nephrology | Issue 8/2015

Login to get access

Abstract

Purpose

To compare the androgen receptor (AR) status of the appendix testis (AT) in congenital undescended and retractile testes.

Materials and methods

Twenty-four appendix testes (AT) were removed from 21 boys to detect AR expression by immunohistochemistry and immunofluorescence staining. Group 1 (n = 3) includes ATs from three patients with unilateral and group 2 (n = 6) with bilateral congenital undescended testis. All patients with bilateral form had been previously treated with human chorionic gonadotropin (hCG) without an acceptable effect. Group 3 (n = 12) includes ATs collected from 12 boys with acquired undescended testis or retractile testicle. Group 4 (n = 3) includes ATs from three young adults who received hCG treatment for undescended testis in their childhood and underwent open testicular biopsy to investigate infertility. Further seven ATs were collected to detect AR mRNA using RT-PCR analysis.

Results

Both immunohistochemistry and immunofluorescence staining of ATs showed AR expression in 100 % of the cases in groups 3 and 4 (12/12 and 3/3), but there was no visible AR expression in groups 1 and 2 (0/3 and 0/6); however, RT-PCR analysis revealed mRNA expression of AR both in congenital undescended and in retractile testicles.

Conclusions

The presence of AR in the epithelial cells of AT in patients with retractile testicle and its absence in patients with congenital undescended testis can be a possible cause of the effectiveness of hormonal treatment in retractile testis and its inefficacy in patients with congenital undescended testis.
Literature
1.
go back to reference Atkinson GO Jr, Patrick LE, Ball TI Jr, Stephenson CA, Broecker BH, Woodard JR (2009) The normal and abnormal scrotum in children: evaluation with color Doppler sonography. AJR 158:613–617CrossRef Atkinson GO Jr, Patrick LE, Ball TI Jr, Stephenson CA, Broecker BH, Woodard JR (2009) The normal and abnormal scrotum in children: evaluation with color Doppler sonography. AJR 158:613–617CrossRef
2.
go back to reference Johnson KA, Dewbury KC (1996) Ultrasound imaging of the appendix testis and appendix epididymis. Clin Radiol 51:335–337PubMedCrossRef Johnson KA, Dewbury KC (1996) Ultrasound imaging of the appendix testis and appendix epididymis. Clin Radiol 51:335–337PubMedCrossRef
3.
go back to reference Józsa T, Csízy I, Kutasy B, Cserni T, Flaskó T (2008) Decreased incidence of appendix testis in cryptorchidism with intraoperative survey. Urol Int 80:317–320PubMedCrossRef Józsa T, Csízy I, Kutasy B, Cserni T, Flaskó T (2008) Decreased incidence of appendix testis in cryptorchidism with intraoperative survey. Urol Int 80:317–320PubMedCrossRef
4.
go back to reference Sahni D, Jit I, Joshi K, Sanjeev S (1996) Incidence and structure of the appendices of the testis and epididymis. J Anat 189:341–348PubMedCentralPubMed Sahni D, Jit I, Joshi K, Sanjeev S (1996) Incidence and structure of the appendices of the testis and epididymis. J Anat 189:341–348PubMedCentralPubMed
5.
go back to reference Tostes GD, Costa SF, de Carvalho JP, Costa WS, Sampaio FJ, Favorito LA (2013) Structural analysis of testicular appendices in patients with cryptorchidism. Int Braz J Urol 39:240–247PubMed Tostes GD, Costa SF, de Carvalho JP, Costa WS, Sampaio FJ, Favorito LA (2013) Structural analysis of testicular appendices in patients with cryptorchidism. Int Braz J Urol 39:240–247PubMed
6.
go back to reference Józsa T, Dienes B, Telek A, Hargitai Z, Pór A, Kiss C (2008) Differential expression of androgen and estrogen receptor of appendix testis in patients with descended and undescended testes. Int J Urol 15:171–174PubMedCrossRef Józsa T, Dienes B, Telek A, Hargitai Z, Pór A, Kiss C (2008) Differential expression of androgen and estrogen receptor of appendix testis in patients with descended and undescended testes. Int J Urol 15:171–174PubMedCrossRef
7.
go back to reference Ritzén EM, Bergh A, Bjerknes R, Christiansen P, Cortes D, Haugen SE, Jörgensen N, Kollin C, Lindahl S, Läckgren G, Main KM, Nordenskjöld A, Rajpert-De Meyts E, Söder O, Taskinen S, Thorsson A, Thorup J, Toppari J, Virtanen H (2007) Nordic consensus on treatment of undescended testes. Acta Paediatr 96:638–643PubMedCrossRef Ritzén EM, Bergh A, Bjerknes R, Christiansen P, Cortes D, Haugen SE, Jörgensen N, Kollin C, Lindahl S, Läckgren G, Main KM, Nordenskjöld A, Rajpert-De Meyts E, Söder O, Taskinen S, Thorsson A, Thorup J, Toppari J, Virtanen H (2007) Nordic consensus on treatment of undescended testes. Acta Paediatr 96:638–643PubMedCrossRef
8.
9.
go back to reference Schapiro B (1957) 25 Years of hormonal treatment of cryptorchidism. Harefuah 15(53):198–199 Schapiro B (1957) 25 Years of hormonal treatment of cryptorchidism. Harefuah 15(53):198–199
10.
go back to reference Pyörälä S, Huttunen NP, Uhari M (1995) A review and meta-analysis of hormonal treatment of cryptorchidism. J Clin Endocrinol Metab 80:2795–2799PubMed Pyörälä S, Huttunen NP, Uhari M (1995) A review and meta-analysis of hormonal treatment of cryptorchidism. J Clin Endocrinol Metab 80:2795–2799PubMed
11.
go back to reference Henna MR, Del Nero RG, Sampaio CZ, Atallah AN, Schettini ST, Castro AA et al (2004) Hormonal cryptorchidism therapy: systematic review with metanalysis of randomized clinical trials. Pediatr Surg Int 20:357–359PubMedCrossRef Henna MR, Del Nero RG, Sampaio CZ, Atallah AN, Schettini ST, Castro AA et al (2004) Hormonal cryptorchidism therapy: systematic review with metanalysis of randomized clinical trials. Pediatr Surg Int 20:357–359PubMedCrossRef
12.
go back to reference Miller OF, Stock JA, Cilento BG, McAleer IM, Kaplan GW (2003) Prospective evaluation of human chorionic gonadotropin in the differentiation of undescended testes from retractile testes. J Urol 169:2328–2331PubMedCrossRef Miller OF, Stock JA, Cilento BG, McAleer IM, Kaplan GW (2003) Prospective evaluation of human chorionic gonadotropin in the differentiation of undescended testes from retractile testes. J Urol 169:2328–2331PubMedCrossRef
13.
go back to reference Dunkel L, Taskinen S, Hovatta O, Tilly JL, Wikstrom S (1997) Germ cell apoptosis after treatment of cryptorchidism with human chorionic gonadotropin is associated with impaired reproductive function in the adult. J Clin Invest 100:2341–2346PubMedCentralPubMedCrossRef Dunkel L, Taskinen S, Hovatta O, Tilly JL, Wikstrom S (1997) Germ cell apoptosis after treatment of cryptorchidism with human chorionic gonadotropin is associated with impaired reproductive function in the adult. J Clin Invest 100:2341–2346PubMedCentralPubMedCrossRef
14.
go back to reference Ong C, Hasthorpe S, Hutson JM (2005) Germ cell development in the descended and cryptorchid testis and the effects of hormonal manipulation. Pediatr Surg Int 21:240–254PubMedCrossRef Ong C, Hasthorpe S, Hutson JM (2005) Germ cell development in the descended and cryptorchid testis and the effects of hormonal manipulation. Pediatr Surg Int 21:240–254PubMedCrossRef
15.
go back to reference Hadziselimovic F, Zivkovic D (2007) Is the prohibition of hormonal treatment for cryptorchidism, as suggested by the Nordic consensus group, justifiable? Acta Paediatr 96:1368–1369PubMedCrossRef Hadziselimovic F, Zivkovic D (2007) Is the prohibition of hormonal treatment for cryptorchidism, as suggested by the Nordic consensus group, justifiable? Acta Paediatr 96:1368–1369PubMedCrossRef
16.
go back to reference Abacı A, Çatlı G, Anık A, Böber E (2013) Epidemiology, classification and management of undescended testes: does medication have value in its treatment? J Clin Res Pediatr Endocrinol 5:65–72PubMedCentralPubMedCrossRef Abacı A, Çatlı G, Anık A, Böber E (2013) Epidemiology, classification and management of undescended testes: does medication have value in its treatment? J Clin Res Pediatr Endocrinol 5:65–72PubMedCentralPubMedCrossRef
17.
go back to reference Józsa T, Telek A, Kutasy B, Benyó M, Csanádi G, Kovács I, Balla G, Flaskó T, Csernoch L, Kiss C (2009) Effect of hydrocele on appendix testis in children. Asian J Androl 11:741–745PubMedCentralPubMedCrossRef Józsa T, Telek A, Kutasy B, Benyó M, Csanádi G, Kovács I, Balla G, Flaskó T, Csernoch L, Kiss C (2009) Effect of hydrocele on appendix testis in children. Asian J Androl 11:741–745PubMedCentralPubMedCrossRef
18.
go back to reference Kolon TF, Herndon CD, Baker LA, Baskin LS, Baxter CG, Cheng EY, Diaz M, Lee PA, Seashore CJ, Tasian GE, Barthold JS (2014) American Urological Association Evaluation and treatment of cryptorchidism: AUA guideline. J Urol 192:337–345PubMedCrossRef Kolon TF, Herndon CD, Baker LA, Baskin LS, Baxter CG, Cheng EY, Diaz M, Lee PA, Seashore CJ, Tasian GE, Barthold JS (2014) American Urological Association Evaluation and treatment of cryptorchidism: AUA guideline. J Urol 192:337–345PubMedCrossRef
20.
go back to reference Mathers MJ, Sperling H, Rübben H, Roth S (2009) The undescended testis: diagnosis, treatment and long-term consequences. Dtsch Arztebl Int 106:527–532PubMedCentralPubMed Mathers MJ, Sperling H, Rübben H, Roth S (2009) The undescended testis: diagnosis, treatment and long-term consequences. Dtsch Arztebl Int 106:527–532PubMedCentralPubMed
21.
go back to reference Schwentner C, Oswald J, Kreczy A, Lunacek A, Bartsch G, Deibl M, Radmayr C (2005) Neoadjuvant gonadotropin-releasing hormone therapy before surgery may improve the fertility index in undescended testes: a prospective randomized trial. J Urol 173(974–977):22 Schwentner C, Oswald J, Kreczy A, Lunacek A, Bartsch G, Deibl M, Radmayr C (2005) Neoadjuvant gonadotropin-releasing hormone therapy before surgery may improve the fertility index in undescended testes: a prospective randomized trial. J Urol 173(974–977):22
22.
go back to reference Hadziselimović F, Herzog B (1997) Treatment with a luteinizing hormone-releasing hormone analogue after successful orchiopexy markedly improves the chance of fertility later in life. J Urol 158:1193–1195PubMedCrossRef Hadziselimović F, Herzog B (1997) Treatment with a luteinizing hormone-releasing hormone analogue after successful orchiopexy markedly improves the chance of fertility later in life. J Urol 158:1193–1195PubMedCrossRef
23.
go back to reference Huff DS, Snyder HM 3rd, Rusnack SL, Zderic SA, Carr MC, Canning DA (2001) Hormonal therapy for the subfertility of cryptorchidism. Horm Res 55:38–40PubMedCrossRef Huff DS, Snyder HM 3rd, Rusnack SL, Zderic SA, Carr MC, Canning DA (2001) Hormonal therapy for the subfertility of cryptorchidism. Horm Res 55:38–40PubMedCrossRef
24.
go back to reference Hjertkvist M, Bergh A, Damber JE (1988) HCG treatment increases intratesticular pressure in the abdominal testis of unilaterally cryptorchid rats. J Androl 9:116–120PubMed Hjertkvist M, Bergh A, Damber JE (1988) HCG treatment increases intratesticular pressure in the abdominal testis of unilaterally cryptorchid rats. J Androl 9:116–120PubMed
25.
go back to reference Samnakay N, Cohen RJ, Orford J, King PA, Davies RJ (2003) Androgen and oestrogen receptor status of the human appendix testis. Pediatr Surg Int 19:520–524PubMedCrossRef Samnakay N, Cohen RJ, Orford J, King PA, Davies RJ (2003) Androgen and oestrogen receptor status of the human appendix testis. Pediatr Surg Int 19:520–524PubMedCrossRef
26.
go back to reference Metin A, Kayigil O, Ahmed SI (2005) The efficacy of human chorionic gonadotropin in retractile testis. Neuro Endocrinol Lett 26:39–42PubMed Metin A, Kayigil O, Ahmed SI (2005) The efficacy of human chorionic gonadotropin in retractile testis. Neuro Endocrinol Lett 26:39–42PubMed
Metadata
Title
Correlation between the androgen receptor status of the appendix testis and the efficacy of human chorionic gonadotropin treatment in undescended testis
Authors
Gyula Drabik
Tamás Józsa
Olga Ruzsnavszky
Kornél Kistamás
Beatrix Dienes
Ilona Kovacs
Mátyás Benyó
Tibor Flaskó
Publication date
01-08-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 8/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-1037-6

Other articles of this Issue 8/2015

International Urology and Nephrology 8/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.